Disulfiram for stage III or IV stomach cancer without surgery
Treatments studied
Part of Cancer clinical trials.
This trial studies whether disulfiram, a medicine sometimes used for alcohol dependence, can help people with advanced stomach (gastric) cancer who choose not to have surgery. You may be eligible if you’re well enough to take pills and your cancer is confirmed and advanced (stage III–IV).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older
- Your stomach cancer is confirmed by a biopsy during a scope (gastroscopy)
- Your cancer is stage III or IV, and you do not want surgery
- You’re expected to live more than 3 months
- You haven’t had chemotherapy in the last month (or at all before starting)
- You can do daily activities at least “moderately well” (Karnofsky score 60 or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding disitamab vedotin (a drug that targets HER2) to standard chemotherapy (SOX) after surgery for stage 3 stomach cancer. The goal is to see if the combination works better than chemo alone to prevent cancer from coming back.
This trial is testing a combination of three medicines—an immunotherapy (anti-PD-1), an immune booster (thymalfasin), and a chemotherapy regimen (SOX)—given before surgery to shrink stage III stomach or gastroesophageal junction cancer and improve outcomes.
This trial is for people with advanced stomach cancer that has shrunk after initial chemotherapy or targeted therapy. It compares whether adding surgery to continued medical treatment is better than staying on medical treatment alone, with the goal of improving outcomes.
This early-stage study tests a combination of disulfiram (an anti-alcohol medication), copper, and liposomal doxorubicin (a chemotherapy form) in people with sarcoma that has come back or did not respond to treatment. It aims to shrink or control tumors and improve outcomes when standard options have not worked.
This trial tests whether disulfiram (a medicine) combined with copper can help after surgery in people with newly diagnosed glioblastoma. It aims to improve outcomes by adding treatment before (or instead of) standard chemoradiation starts.
This trial tests a combination of two targeted drugs (fruquintinib and sintilimab) plus standard chemotherapy for people with advanced stomach or gastroesophageal junction cancer that has not been treated before. The goal is to see if this combination can help shrink or control the cancer.
Hear when a new Chemotherapy；Advanced Gastric Cancer；Cisplatin；Disulfiram trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.